The findings indicate that AYN has the potential to activate the AMPKα/GLUT4 signaling pathway in both in vivo and in vitro settings, thereby ameliorating hyperglycemia associated with diabetes. The gene discussed is SLC2A4; the disease is Hyperglycemia.